Showing results (421-430 of 466) with videos related to

Sort By:
Pageof 47
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2020
The Impact of Donor Type on Outcomes and Cost of Allogeneic Hematopoietic Cell Transplantation for Pediatric Leukemia: A Merged Center for International Blood and Marrow Transplant Research and Pediatric Health Information System AnalysisStaci D Arnold, Ruta Brazauskas, Naya He, et al.
Transplantation and Cellular Therapy|July 21, 2024
Impact of Race and Ethnicity on Outcomes After Umbilical Cord Blood TransplantationKaren Ballen, Tao Wang, Naya He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2016
Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell TransplantationKaren Ballen, Kwang Woo Ahn, Min Chen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 3, 2017
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of AgeLynda M Vrooman, Heather R Millard, Ruta Brazauskas, et al.
Bone Marrow Transplantation|January 5, 2016
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysisK M Williams, K W Ahn, M Chen, et al.
Cancer|November 11, 2017
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphomaRegina M Myers, Brian T Hill, Bronwen E Shaw, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 31, 2006
Pretransplantation consolidation chemotherapy decreases leukemia relapse after autologous blood and bone marrow transplants for acute myelogenous leukemia in first remissionMartin S Tallman, Waleska S Pérez, Hillard M Lazarus, et al.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 4, 2019
Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell TransplantationBetty K Hamilton, Ying Liu, Michael T Hemmer, et al.
Blood|April 25, 2021
Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALLElisabeth Paietta, Kathryn G Roberts, Victoria Wang, et al.
Pageof 47